• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Lab Med . Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses

tetano

Editor, Senior Moderator
Clin Lab Med


. 2022 Mar;42(1):97-109.
doi: 10.1016/j.cll.2021.10.002. Epub 2021 Nov 3.
Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses


Alana F Ogata[SUP] 1 [/SUP], Roey Lazarovits[SUP] 2 [/SUP], Augusta Uwamanzu-Nna[SUP] 3 [/SUP], Tal Gilboa[SUP] 1 [/SUP], Chi-An Cheng[SUP] 1 [/SUP], David R Walt[SUP] 4 [/SUP]



Affiliations

Abstract

Humoral immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during acute infection and convalescence has been widely studied since March 2020. In this review, the authors summarize literature on humoral responses to SARS-CoV-2 antigens with a focus on spike, nucleocapsid, and the receptor-binding domain as targets of antibody responses. They highlight serologic studies during acute SARS-CoV-2 infection and discuss the clinical relevance of antibody levels in COVID-19 progression. Antibody responses in pediatric COVID-19 patients are also reviewed. Finally, the authors discuss antibody responses during convalescence and their role in protection from SARS-CoV-2 reinfection.

Keywords: Antigen-antibody responses; Coronavirus antigens; Humoral immunity; SARS-CoV-2.
 
Back
Top Bottom